The Potential of Psidium Guajava as an Antidiabetic a Review
Keywords:
Psidium guajava, bioactive compounds, antihiperglicemicAbstract
Psidium guava is known as a fruit that contains many bioactive compounds such as polyphenols, flavonoids, and heteropolysaccharides. This review presents the results of the latest research on the effect of guava fruit on type 2 diabetes mellitus. It is proven that guava fruit can act as an antihyperglycemic therapy through mechanisms that include repairing pancreatic cells, increasing insulin sensitivity, inhibiting α-glucosidase, and inhibiting SGLT1 and GLUT2 transporters. These results prove the potential of guava fruit as a functional food for glycemic control in patients with type 2 diabetes mellitus.
References
Deshpande ad, harris-hayes m, schootman m. Epidemiology of diabetes and diabetes-related complications. Phys Ther. 2008;88(11):1254–64.
Tuttolomondo a, maida c, pinto a. Diabetic foot syndrome as a possible cardiovascular marker in diabetic patients. J Diabet Res. 2015;2015:1–12.
International Diabetes Federation. IDF Diabetes Atlas. 10th Edition. Brussels, Belgium: International Diabetes Federation; 2019.
Bregu a, toçi e, muja h, çanaku d, roshi e. Diabetes Management: A Literature Review. Alban Med J. 2012;4:86–92.
Sola d, rossi l, schianca gp, maffioli p, bigliocca m, mella r, corlianò f, fra gp, bartoli e, derosa g. Sulfonylureas and their use in clinical practice. Arch Med Sci. 2015;11(4):840–8.
Nesto rw, bell d, bonow ro, fonseca v, grundy sm, horton es, et al. Thiazolidinedione use, fluid retention, and congestive heart failure. A Consensus Statement from the American Heart Association and American Diabetes Association. Diabetes Care. 2004. 27(1):256–63.
Bolen s, feldman l, vassy j, wilson l, yeh ch, marinopoulos s, et al. Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus. Ann Intern Med. 2007;147(6):386–99.
Unuofin jo, lebelo sl. Antioxidant effects and mechanisms of medicinal plants and their bioactive compounds for the prevention and treatment of type 2 diabetes: an updated review. Oxid Med Cell Longev. 2020;2020:1–36.
Li py, hsu cc, yin mc, kuo yh, tang fy, chao cy. Protective effects of red guava on inflammation and oxidative stress in streptozotocin-induced diabetic mice. Molecules. 2015;20(12):22341–50.
Lin cf, kuo yt, chen ty, chien ct. Quercetin-rich guava (Psidium guajava) juice in combination with trehalose reduces autophagy, apoptosis and pyroptosis formation in the kidney and pancreas of type II diabetic rats. Molecules. 2016;21(3):1–18.
Jiao y , hua d , huang d , zhang q , yan c . Characterization of a new heteropolysaccharide from green guava and its application as an α-glucosidase inhibitor for the treatment of type II diabetes. Food Funct. 2018;9(7):3997–4007.
Müller u, stübl f, schwarzinger b, sandner g, iken m, himmelsbach m, schwarzinger c, ollinger n, stadlbauer v, höglinger o, kühne t, lanzerstorfer p, weghuber j. In vitro and in vivo inhibition of intestinal glucose transport by guava (Psidium guajava) extracts. Mol Nutr Food Res. 2018;62(11):1–11.
König a, schwarzinger b, stadlbauer v, et al. Guava (Psidium guajava) fruit extract prepared by supercritical co2 extraction inhibits intestinal glucose resorption in a double-blind, randomized clinical study. Nutrients. 2019;11(7):1–13.
Kumari n, gautam s, ashutosh c. Psidium guajava a fruit or medicine - an overview. Pharma Innovation. 2013;2(8):63–7.
Shukla s. Quantification of bioactive compounds in guava at different ripening stages. Food Research. 2021;5(3):183–9.
Vijaya anand a, velayuthaprabhu s, rengarajan rl, sampathkumar p, radhakrishnan r. Bioactive compounds of guava (Psidium guajava L.). 2020. In: Murthy h, bapat v. (eds) Bioactive compounds in underutilized fruits and nuts. Springer, Cham.
Nordmann tm, dror e, schulze f, traub s, berishvili e, barbieux c, et al. The Role of Inflammation in β-cell Dedifferentiation. Scientific Reports. 2017;7(1):1–10.
Rao m, sreenivasulu m, chengaiah b, reddy kj, chetty cm. Herbal medicines for diabetes mellitus: a review. J Pharm Tech Res. 2019;4(3):1883–92.
Bnouham m, ziyyat a, mekhfi h, tahri a, legssyer a. Medicinal plants with potential anti diabetic activity – a review of ten years of herbal medicine research. Int J Diabetes & Metabolism. 2006;14:1–25.
Ismawanti z, suparyatmo, wiboworini b. The comparative effect of red guava (psidium guajava. l.) with papaya (carica papaya) on blood glucose level of type 2-diabetic patients. Romanian J Diabetes Nutr Metab Dis. 2020;27(3):209–13.
Derosa g, maffioli p. α-Glucosidase inhibitors and their use in clinical practice. Arch Med Sci. 2012;8(5):899–906.
Derosa g, mereu r, d'angelo a, salvadeo sa, ferrari i, fogari e, et al. Effect of pioglitazone and acarbose on endothelial inflammation biomarkers during oral glucose tolerance test in diabetic patients treated with sulphonylureas and metformin. J Clin Pharm Ther. 2010;35(5):565–79.
Jiao y, zhang m, wang s, yan c. Consumption of guava may have beneficial effects in type 2 diabetes: A bioactive perspective. Int J Biol Macromol. 2017;101:543–52.
Chan lk, leung ps. Multifaceted interplay among mediators and regulators of intestinal glucose absorption: potential impacts on diabetes research and treatment. Am J Physiol Endocrinol Metab. 2015;309(11):887–99.
Kwon o, eck p, chen s, corpe cp, lee jh, kruhlak m, levine m. Inhibition of the intestinal glucose transporter GLUT2 by flavonoids. FASEB J. 2007;21(2):366–77.
